Forte Biosciences, Inc. (FBRX)

76.99 0.00 (0.00%) USD  |  NASDAQ  |  Aug 31, 16:00
More

Forte Biosciences Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for FBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
July 27, 2026 --
July 09, 2026 --
May 13, 2026 --
May 11, 2026 --
April 06, 2026 --
April 02, 2026 --
April 01, 2026 --
March 31, 2026 --
February 20, 2026 --
December 30, 2025 --
November 25, 2025 --
November 17, 2025 --
November 14, 2025 --
August 18, 2025 --
August 16, 2025 --
August 15, 2025 --
June 30, 2025 --
June 24, 2025 --
Date Value
June 05, 2025 --
May 16, 2025 --
May 15, 2025 --
April 03, 2025 --
April 01, 2025 --
March 31, 2025 --
January 21, 2025 --
November 15, 2024 --
September 03, 2024 --
August 19, 2024 --
August 15, 2024 --
May 29, 2024 --
May 14, 2024 --
April 28, 2024 --
April 08, 2024 --
November 14, 2023 --
October 31, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
argenx SE Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade